Form 8-K - Current report:
SEC Accession No. 0001437749-24-004172
Filing Date
2024-02-14
Accepted
2024-02-14 16:33:22
Documents
16
Period of Report
2024-02-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20240214_8k.htm   iXBRL 8-K 29511
6 pic1.jpg GRAPHIC 7772
  Complete submission text file 0001437749-24-004172.txt   182605

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20240214.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20240214_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20240214_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20240214_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20240214_8k_htm.xml XML 2834
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 24639237
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)